Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 7 of the 20 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To assess the effectiveness of structured blood glucose testing in poorly controlled, noninsulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: This 12-month, prospective, cluster-randomized, multicenter study recruited 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetic subjects from 34 primary care practices in the U.S. Practices were randomized to an active control group (ACG) with enhanced usual care or a structured testing group (STG) with enhanced usual care and at least quarterly use of structured self-monitoring of blood glucose (SMBG). STG patients and physicians were trained to use a paper tool to collect/interpret 7-point glucose profiles over 3 consecutive days. The primary end point was A1C level measured at 12 months. RESULTS: The 12-month intent-to-treat analysis (ACG, n = 227; STG, n = 256) showed significantly greater reductions in mean (SE) A1C in the STG compared with the ACG: −1.2% (0.09) vs. −0.9% (0.10); Δ = −0.3%; P = 0.04. Per protocol analysis (ACG, n = 161; STG, n = 130) showed even greater mean (SE) A1C reductions in the STG compared with the ACG: −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003. Significantly more STG patients received a treatment change recommendation at the month 1 visit compared with ACG patients, regardless of the patient’s initial baseline A1C level: 179 (75.5%) vs. 61 (28.0%); <0.0001. Both STG and ACG patients displayed significant (P < 0.0001) improvements in general well-being (GWB). CONCLUSIONS: Appropriate use of structured SMBG significantly improves glycemic control and facilitates more timely/aggressive treatment changes in noninsulin-treated type 2 diabetes without decreasing GWB.
Overview
CoChat Summary
TL;DR
In poorly controlled, insulin-naïve type 2 diabetes, structured self-monitoring of blood glucose (SMBG) plus enhanced usual care reduced A1C significantly more than enhanced usual care alone over 12 months. It also produced more timely treatment changes without decreasing general well-being.
Key findings
- In the intent-to-treat analysis (ACG n = 227; STG n = 256), mean (SE) A1C reductions were −1.2% (0.09) for STG vs. −0.9% (0.10) for ACG; Δ = −0.3%; P = 0.04. Per-protocol reductions were −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003.
- Significantly more STG patients received a treatment change recommendation at month 1: 179 (75.5%) vs. 61 (28.0%); P < 0.0001. Mean (SD) scheduled visits with a treatment change recommendation were 2.7 (1.5) vs. 1.1 (1.0); P < 0.0001. More STG patients started intermediate- or long-acting insulin: 42 vs. 23; P = 0.046.
- STG subjects showed reduced preprandial-to-postprandial glucose excursions from month 1 to month 12: breakfast 44 to 35 mg/dL (P < 0.005), lunch 25 to 17 mg/dL (P < 0.03), supper 34 to 26 mg/dL (P < 0.05). Mean amplitude of glucose excursions fell from 38.5 (0.9) to 34.3 (1.0) mg/dL (P = 0.0003).
- General well-being improved in both groups (ACG P < 0.007; STG P < 0.0001), with no significant between-group difference over time; per-protocol adherent STG subjects had greater improvement than adherent ACG subjects (P < 0.04).
Methods
- 12-month prospective, cluster-randomized, multicenter study in 34 U.S. primary care practices randomized to active control (ACG, n = 13 practices) or structured testing (STG, n = 21 practices); 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetes patients were included in the intent-to-treat cohort (ACG n = 227; STG n = 256).
- STG patients and physicians used the Accu-Chek 360° View tool to collect/interpret 7-point glucose profiles over 3 consecutive days before scheduled visits; ACG received enhanced usual care only. Primary endpoint was A1C at 12 months.
- Linear mixed models compared groups over time, controlling for baseline A1C, age, gender, and race as fixed effects and practice site and subject as random effects; intent-to-treat and per-protocol analyses were performed.
Limitations
- Stated: no third study arm assessed the effect of increased attention in both groups; the study could not determine whether treatment changes were clinically appropriate, because it measured number rather than type of change; it could not determine how many recommended changes actually occurred; and STG had greater attrition than ACG (not statistically significant), possibly reflecting intervention burden and biasing findings.
- Evident from the text: the ACG received enhanced usual care, free meters/strips, and more frequent visits, so between-group differences may be conservative; per-protocol results depend on adherence definitions and exclusion of nonadherent STG patients, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
4 Valid · 1 Not valid · 4 Not checked · 51 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Inconsistent findings seen in studies of insulin-naïve type 2 diabetic patients may be due, in part, to differences in key design issues, such as subject selection criteria (e.g., whether or not patients had poor glycemic control at study entry), critical content differences in the actual SMBG intervention (e.g., whether physicians were privy to patient SMBG data), fidelity of treatment delivery (”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > Abstract > CONCLUSIONS
What the sources say
- Supportedcites [14] Polonsky, 2010, The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986], BMC Fam Pract source
The Background summary says that differences in SMBG protocols and study designs have left findings in insulin-naïve type 2 diabetes unclear. Its sections on baseline HbA1c, HCP use of SMBG data, and completion of the prescribed protocol address subject selection, intervention content and delivery, and adherence. Page numbers are not available in our copy. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Measurements of mean amplitude of glucose excursions indicated significant (P = 0.0003) mean (SE) reductions in glycemic variability among STG subjects from 38.5 mg/dL (0.9) at month 1 to 34.3 mg/dL (1.0) at month 12.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no changes in these findings when insulin-using patients were excluded from the analyses.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PP analyses revealed that adherent STG subjects reported a significantly greater improvement in GWB than adherent ACG subjects (P < 0.04).”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > General well-being
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar between-group differences occurred using last observation carried forward analysis (last A1C before insulin start carried forward): −1.0% (0.10) vs. −0.7% (0.10); Δ = −0.3%; P = 0.03.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Changes in treatment
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
25 more claims
Create a free account to see all 60 claims and to verify the 2 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“per protocol analysis of the STeP study showed a significant between-group difference, favoring sSMBG, for general emotional well-being (WHO-5), regimen-related diabetes distress (DDS subscale), and diabetes-specific self-efficacy (CIDS) (61, 62, 64).”
From The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis (2023) · cites this paper as [61]
Experimental — accuracy not yet measuredIn the citing paper
“In a year-long study of insulin-naive people with diabetes with suboptimal initial glycemic outcomes, a group trained in structured BGM (a paper tool was used at least quarterly to collect and interpret seven-point BGM profiles taken on three consecutive days) reduced their A1C levels by 0.3% more than the control group (32).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [32]
In the citing paper
“To optimally benefit from structured SMBG, the obtained BG values therefore have to be actively used by PwD or healthcare professionals (HCPs) for therapeutic decisions or therapy adjustments, such as changes in eating behavior, lifestyle and/or anti-diabetic therapy [9].”
From Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus (2022) · cites this paper as [9]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,384
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Bech, P., Olsen, L. R., Kjoller, M., & Rasmussen, N. K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.145 · Cited by 1,015 · cited 1×
“GWBwas measured using theWHO-5 Well-Being Index assessment tool (17), a widely used, five-item questionnaire with a total score range of from 0–100 (higher scores indicatingmorepositivewell-being).”
Method(2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 699
Cited by
Items 201–300 of 426
Trask, L. E., Chaidarun, S., Platt, D., & Parkin, C. G. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814538939 · Cited by 14
Self-citationIntensified glucose self-monitoring with education in Saudi DM patients.
Ba-Essa, E. M., Mobarak, E., Alghamdi, A., & Al‐Daghri, N. M. (2015) · PubMed · Cited by 14
Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania
Čokolič, M., Lalic, N. M., Micić, D., Mirošević, G., Majanović, S. K., Lefterov, I., & Graur, M. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-1143-1 · Cited by 14
“The appropriate use of structured self-monitoring of blood glucose significantly improves glycemic control and facilitates adherence to recommendations about nutrition and physical activity as well as more timely and aggressive treatment changes without decreasing general wellbeing [28].”
BackgroundWieringa, T. H., de Wit, M., Twisk, J. W. R., & Snoek, F. J. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000548 · Cited by 13
Weissmann, J., Mueller, A., Messinger, D., Parkin, C. G., & Amann-Zalán, I. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815595984 · Cited by 14
Self-citationElectrochemical Glucose Biosensors for Diabetes Care
Ocvirk, G., Buck, H., & DuVall, S. H. (2016) · Bioanalytical reviews · doi:10.1007/11663_2016_3 · Cited by 16
“5%) insulin-naı̈ve T2DM patients from 34 US primary care practices [127].”
BackgroundFreckmann, G., Baumstark, A., Jendrike, N., Mende, J., Schauer, S., Link, M., Pleus, S., & Haug, C. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820948873 · Cited by 12
Hauss, O., Hinzmann, R., & Huffman, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221140420 · Cited by 17
Efficacy of a Computerized Simulation in Promoting Walking in Individuals With Diabetes
Gibson, B., Marcus, R. L., Staggers, N., Jones, J., Samore, M. H., & Weir, C. R. (2012) · Journal of Medical Internet Research · doi:10.2196/jmir.1965 · Cited by 13
Patient self-testing in chronic disease management
O’Kane, M. (2019) · Journal of Laboratory Medicine · doi:10.1515/labmed-2019-0175 · Cited by 13
Testing times! Choosing Wisely when it comes to monitoring type 2 diabetes
Speight, J., Browne, J. L., & Furler, J. S. (2015) · Medical Journal of Australia · doi:10.5694/mja15.00639 · Cited by 12
Structured SMBG in early management of T2DM: Contributions from the St Carlos study
Gracia, T. R., Lobo, N. G. D. L. T., Hervada, A. D. R., & Pascual, A. L. C. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.471 · Cited by 11
Hirsch, I. B., Nardacci, E., & Verderese, C. A. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0059 · Cited by 14
Persson, D. R., Zhukouskaya, K., Wegener, A.-M. K., Jørgensen, L. K., Bardram, J. E., & Bækgaard, P. (2023) · JMIR Formative Research · doi:10.2196/49738 · Cited by 11
Dijkstra, A. M., van Vliet, K., MacDonald, A., Ahring, K., Abeln, D., Ford, S., Hildebrandt-Karlsen, S., van Spronsen, F. J., & Heiner-Fokkema, M. R. (2024) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2024.108361 · Cited by 11
Bietenbeck, A., Junker, R., & Luppa, P. B. (2015) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000043 · Cited by 12
Segal, A. R., Vootla, T., & Beaser, R. S. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.009 · Cited by 14
Chang, Y.-T., Tu, Y.-Z., Chiou, H., Lai, K., & Yu, N. C. (2022) · JMIR mhealth and uhealth · doi:10.2196/31764 · Cited by 15
Using Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes
Cypress, M., & Tomky, D. M. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.2.102 · Cited by 16
Sieber, J., Flacke, F., Link, M., Haug, C., & Freckmann, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0306-z · Cited by 11
Greenwood, D. A., & Grady, M. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820946112 · Cited by 13
Harashima, S., Nishimura, A., Ikeda, K., Wang, Y., Liu, Y., & Inagaki, N. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815608869 · Cited by 15
Oh, H., & Ell, K. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.04.003 · Cited by 11
“Activated self-care behaviors are associated with better diabetes outcomes [3,4].”
BackgroundPsychological Factors and Diabetes Mellitus
Pouwer, F., & Speight, J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch56 · Cited by 12
Ordoñez, J. S. F., & Pérez-Gualdrón, C. E. (2019) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v67n3.69687 · Cited by 11
“(16,19-21) The role of patient education in self-care is to make patients aware of their condition and the importance of controlling the disease, since this will help improving their health condition and their quality of life.”
BackgroundInfluentialTanaka, N., Yabe, D., Murotani, K., Yamaguchi, Y., Fujita, Y., Kubota, S., Nakashima‐Yasuda, R., Kubota‐Okamoto, S., Ueno, S., Yamazaki, Y., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13607 · Cited by 13
Wang, J., Lo, S., Yeh, Y., Hwu, C., Huang, C., Hsieh, C., & Sheu, W. H. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14410 · Cited by 12
Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?
Wright, E. E., & Subramanian, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0025 · Cited by 13
Psychosocial and behavioral correlates of A1C and quality of life among young adults with diabetes
Vigen, C. L. P., Carandang, K., Blanchard, J., Sequeira, P. A., Wood, J. R., Spruijt-Metz, D., Whittemore, R., Peters, A. L., & Pyatak, E. A. (2018) · The Diabetes Educator · doi:10.1177/0145721718804170 · Cited by 6
Virdi, N. S., Lefèbvre, P., Parisé, H., Duh, M. S., Pilon, D., Laliberté, F., Sundaresan, D., Garber, L., & Dirani, R. D. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700513 · Cited by 11
Assessing glycaemic control: self-monitoring of blood glucose
Wilson, D. D., McAllister, G., & West, A. (2011) · British Journal of Nursing · doi:10.12968/bjon.2011.20.15.919 · Cited by 13
Min, T., Davies, G. I., Rice, S., Chess, J. A., & Stephens, J. W. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.11.002 · Cited by 10
Yimer, Y. S., Addissie, A., Kidane, E. G., Reja, A., Abdela, A. A., & Ahmed, A. A. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1554524 · Cited by 24
Assessing System Accuracy of Blood Glucose Monitoring Systems Using Rectangle Target Plots
Müller, P., Hattemer, A., & Stephan, P. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815612496 · Cited by 10
Point of Care Testing—Current and Emerging Quality Perspectives
O’Kane, M. (2014) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.10.1097/poc.0000000000000008 · Cited by 11
If SMBG Accuracy Is Critical to Patient Safety, Why Are Inaccurate Meters Still on the Market?
Parkin, C. G. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817693256 · Cited by 11
Self-citationYi, W. M., Jones, E. M. V. W., Hansen, B. K., & Vora, J. (2019) · PubMed · Cited by 9
Recognizing and minimizing hypoglycemia: The need for individualized care
Lavernia, F., Kushner, P. R., Trence, D., Rice, D., DAILEY, G. E., & Kuritzky, L. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1086628 · Cited by 11
Furler, J., O'Neal, D. N., Speight, J., Blackberry, I., Manski-Nankervis, J.-A. E., Thuraisingam, S., Rue, K. D. L., Ginnivan, L., Browne, J. L., Holmes‐Truscott, E., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021435 · Cited by 12
“19 However, nearly 50% of participants either withdrew or did not adhere to the manual monitoring protocol, 18 suggesting the intensive finger-pricking required (eg, seven times per day for three consecutive days) can be a barrier to the real-world implementation of S-SMBG.”
BackgroundHanda, T., Onoue, T., Kobayashi, T., Maeda, R., Mizutani, K., Yamagami, A., Kinoshita, T., Yasuda, Y., Iwama, S., Miyata, T., et al. (2024) · JMIR Diabetes · doi:10.2196/48019 · Cited by 15
Self-monitoring of blood glucose: a promise still unfulfilled?
Heller, S. R. (2014) · Diabetologia · doi:10.1007/s00125-014-3184-1 · Cited by 9
Speight, J., Holmes‐Truscott, E., Thuraisingam, S., Husin, H. M., Manski-Nankervis, J.-A. E., Rue, K. D. L., Ginnivan, L., Audehm, R. G., Clark, M., Khunti, K., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108994 · Cited by 8
Kerr, D., Messing, R., & Resch, A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500635 · Cited by 8
Dérozier, V., Arnavielhe, S., Renard, É., Dray, G., & Martin, S. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819847739 · Cited by 8
Structured Blood Glucose Monitoring in Primary Care: A Practical, Evidence-Based Approach
Logan, A. D., Jones, J., & Kuritzky, L. (2020) · Clinical Diabetes · doi:10.2337/cd20-0045 · Cited by 9
Home Blood Glucose Monitoring in Type 2 Diabetes
Hirsch, I. B. (2011) · Diabetes Care · doi:10.2337/dc10-2238 · Cited by 8
Perceptions of Caribbean type 2 diabetes patients on self-monitoring of blood glucose
Ezenwaka, C. E., Olukoga, A., Onuoha, P. C., Worrell, R., Skinner, T. C., Mayers, H., Martin, E., & Phillip, C. G. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.625950 · Cited by 9
Miikkulainen, K., Caruso, A., Mast, O., Zhang, R., & Borisenko, O. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0102-1 · Cited by 10
Effect of self-monitoring of blood glucose on glycaemic outcome among type 2 diabetic patients
Sodipo, O. O., Adedokun, A., & Olusola, A. A. (2017) · South African Family Practice · doi:10.1080/20786190.2017.1340250 · Cited by 9
Diabetes management intervention studies: lessons learned from two studies
Petersen, B., Vesper, I., Pachwald, B., DAGENBACH, N., Buck, S., Waldenmaier, D., & Heinemann, L. (2021) · Trials · doi:10.1186/s13063-020-05017-3 · Cited by 10
Self-citationMerino-Torres, J. F., Ilham, S., Alshannaq, H. A., Pollock, R. F., Ahmed, W., & Norman, G. J. (2024) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s483459 · Cited by 8
Impact of Behavioral Interventions in the Management of Adults with Type 2 Diabetes Mellitus
Cox, D. J., Taylor, A. G., Dunning, E., Winston, M. C., Van, I. L. L., McCall, A. L., Singh, H., & Yancy, W. S. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0423-7 · Cited by 10
Kim, J. A., Park, M., Song, E., Roh, E., Park, S. Y., Lee, D. Y., Kim, J., Yu, J. H., Seo, J. A., Choi, K. M., et al. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0293 · Cited by 7
“Self-monitoring of blood glucose (SMBG) has been proven to reduce glycosylated hemoglobin (HbA1c) level and is useful for optimizing glycemic control and preventing diabetic complications by helping one understand their pattern of blood glucose level and facilitating lifestyle modifications [1-4].”
BackgroundMansell, K. D., Evans, C. D., Tran, D. A., & Sevany, S. (2015) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163515618420 · Cited by 10
Madeo, B., Diazzi, C., Granata, A. R. M., Ghoch, M. E., Greco, C., Romano, S., Scaltriti, S., & Rochira, V. (2020) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.15586/jptcp.v27isp2.680 · Cited by 9
Open Ecosystem Through Secure Plug and Play Interoperability: An Overview
Fischer, C. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241310253 · Cited by 7
Hayek, A. A., Klonoff, D. C., Zahrani, W. M. A., Saeed, A. H. A., & Dawish, M. A. A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112458 · Cited by 8
Meta-analysis of Telemonitoring to Improve HbA1c Levels: Promises for Stroke Survivors
Taylor, B. L. B. (2014) · International Journal of Neurorehabilitation · doi:10.4172/2376-0281.1000119 · Cited by 6
Tip 2 Diyabetli Bireylerin Hastalık Yönetiminde Karşılaştıkları Engellerin Değerlendirilmesi
Üstündağ, Ş., & Dayapoğlu, N. (2021) · Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.46237/amusbfd.918810 · Cited by 12
Utilization of Blood Glucose Data in Patient Education
Kumah-Crystal, Y. A., & Mulvaney, S. A. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0428-2 · Cited by 7
“Intervention participants displayed significantly greater reductions in distress related to regimen adherence than controls and a greater reduction in glycemic control [24, 56, 57].”
BackgroundMethodSelf-Monitoring of Blood Glucose in Patients with Insulin-Treated Type 2 Diabetes Mellitus
Kim, K. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.26 · Cited by 7
“Song et al. [8] investigated whether this new reimbursement program for SMBG has improved the glycemic control in pa- tients with insulin-treated T2DM.”
BackgroundResultInfluentialImproving Diabetes Care with Technology and Information Management.
Muegge, B. D., & Tobin, G. S. (2016) · Europe PMC (PubMed Central) · Cited by 7
Kim, J. M., Lee, H. J., Kim, K. O., Won, J. C., Ko, K. S., & Rhee, B. D. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.129 · Cited by 6
“The results of SMBG are valuable and useful for treatment only when it is collected well and analyzed exactly [1,2].”
BackgroundSong, Y. S., Koo, B. K., Kim, S. W., Yi, K. H., Shin, K., & Moon, M. K. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.28 · Cited by 8
Kim, H., Yang, Y., Ahn, J., & Kang, J. H. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06575-4 · Cited by 7
Aihara, M., Hayashi, T., Koizumi, C., Sakurai, Y., Sawada, M., Kubota, T., Kadowaki, T., Yamauchi, T., & Kubota, N. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01452-y · Cited by 5
Aihara, M., Yano, K., Irie, T., Nishi, M., Yachiku, K., Minoura, I., Sekimizu, K., Sakurai, Y., Kadowaki, T., Yamauchi, T., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111903 · Cited by 5
Young, L., Buse, J. B., Weaver, M. A., Vu, M. B., Reese, A., Mitchell, C. M., Blakeney, T., Grimm, K. F., Rees, J. R., & Donahue, K. E. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2202-7 · Cited by 6
Mak, W.-H., & Lau, R. W. (2021) · SAGE Open Medicine · doi:10.1177/20503121211066150 · Cited by 7
Direct-to-consumer testing – benefits for consumers, people with disease and public health
Hinzmann, R. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0007 · Cited by 6
(AMD), O. B. O. A. M. D., Ceriello, A., Gallo, M., Gentile, S., Giorda, C. B., & Micheli, A. D. (2012) · Diabetologia · doi:10.1007/s00125-012-2642-x · Cited by 5
Lalic, N. M., Tankova, T. I., Nourredine, M., Parkin, C. G., Schweppe, U., & Amann-Zalán, I. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700134 · Cited by 5
Self-citationSheu, W. H. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00216.x · Cited by 6
Kinchiku, S., Kotani, K., Kajiya, S., Yodo, K., Maruguchi, Y., & Uenomachi, H. (2012) · Journal of Primary Health Care · doi:10.1071/hc12298 · Cited by 5
“(2) The PG–SMBG value difference was smallest at an ambient temperature of 20°C.”
BackgroundParkin, C. G., Schwenke, S., Ossege, A. K., & Gruchmann, T. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816671335 · Cited by 5
Self-citation‘Knowing where I am’: self-monitoring of blood glucose in diabetes
Meetoo, D. D., Wong, L., & Fatani, T. (2018) · British Journal of Nursing · doi:10.12968/bjon.2018.27.10.537 · Cited by 8
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.008 · Cited by 5
Katz, L. B., Grady, M., Stewart, L. S., & Cameron, H. (2016) · Expert Review of Medical Devices · doi:10.1080/17434440.2016.1195260 · Cited by 5
Empowering Diabetes Patient with Mobile Health Technologies
Krošel, M., Švegl, L., Vidmar, L., & Dinevski, D. (2016) · InTech eBooks · doi:10.5772/64620 · Cited by 9
Stephens, J. W., Carman, J. E., Brooks, C. J., Lyons, R. A., Ford, D. V., Price, D. E., & Bain, S. C. (2011) · Diabetes Care · doi:10.2337/dc11-0258 · Cited by 6
Self-Monitoring of Blood Glucose and Type 2 Diabetes: New Tricks for the Old Dog?
Kerr, D. E. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500201 · Cited by 5
2. Glycaemic control assessment and targets in type 2 diabetes
Colagiuri, S., & Ceriello, A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112146 · Cited by 9
System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System
Khan, M. A., Broadbent, K., Morris, M., Ewins, D. L., & Joseph, F. (2014) · Disease Markers · doi:10.1155/2014/602586 · Cited by 4
RetractedFithria, F., Husna, C., Ahyana, A., Nurhidayah, I., & Jannah, S. R. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9634 · Cited by 9
Friedman, K., Noyes, J., & Parkin, C. G. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0304 · Cited by 5
Self-citationPamungkas, R. A., & Chamroonsawasdi, K. (2020) · Frontiers of Nursing · doi:10.2478/fon-2020-0015 · Cited by 13
Alkahtani, A., Anderson, P., & Baysan, A. (2024) · Clinical and Experimental Dental Research · doi:10.1002/cre2.846 · Cited by 4
“In addition, as the duration of diabetes and comorbidity increases, it was previously reported that patients require multiple medications for glycemic control (Polonsky et al., 2011).”
BackgroundMosli, H. H., & Madani, B. (2021) · International Journal of Medicine in Developing Countries · doi:10.24911/ijmdc.51-1611360395 · Cited by 7
Self‐monitoring of blood glucose for type 2 diabetes
Bloomgarden, Z. T., & Ning, G. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12307 · Cited by 4
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M. A., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc11-0365 · Cited by 42
Self-citationAssociation between Sitagliptin Adherence and Self-Monitoring of Blood Glucose
Nigam, S., Virdi, N. S., Daskiran, M., Kozma, C. M., Paris, A., & Dickson, W. M. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600310 · Cited by 5
Katz, L. B., Grady, M., Stewart, L. S., Cameron, H., Anderson, P. A., & Desai, A. A. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.202030 · Cited by 4
“Self-monitoring of blood glucose (SMBG) is recognized as an integral part of diabetes care management in people with Type 1 diabetes (T1D) and Type 2 diabetes (T2D) and provides valuable information for helping them achieve and maintain glycemic control.[1-4] In addition, accurate SMBG results are required for optimal…”
BackgroundSelf-Monitoring of Blood Glucose: One STeP Forward?
Schramm, W. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600432 · Cited by 4
New Technologies for Glucose Monitoring and Insulin Administration
Horwitz, D., & Klonoff, D. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch30 · Cited by 4
Unger, J., Hinnen, D., Schreiner, B., & Parkin, C. (2013) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2012.00736.x · Cited by 4
Self-citationDoes Availability of Reliable Home Blood Glucose Data at Diabetes Appointments Improve Glycemia?
Boyd-Woschinko, G. S., Kaiser, D. L., Diefenbach, M. A., & Tamler, R. (2013) · Endocrine Practice · doi:10.4158/ep13293.or · Cited by 3
Alzaid, A., Schlaeger, C., & Hinzmann, R. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0260 · Cited by 4
“Schweitzer described in detail the role of SMBG and CGM testing in the management of diabetes and reiterated the close correlation known to exist between frequency of SMBG/CGM testing and glycemic control.(6,9,32,36) Schweitzer suggested that SMBG testing would be of limited clinical value only unless two things happe…”
BackgroundMethodInfluentialProblems of blood glucose self-monitoring in patients with diabetes mellitus
Kononova, Y. A., Bregovskiy, V. B., & Babenko, A. Y. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-21-1-140-148 · Cited by 3
SCHMITT, A. J., Beran, M., Geraets, A. F. J., Iversen, M. M., Nefs, G., Nouwen, A., Pouwer, F., Huber, J., & Schram, M. T. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230602124223 · Cited by 5
Molfetta, S. D., Laviola, L., Natalicchio, A., Leonardini, A., Cignarelli, A., Bonizzoni, E., Acmet, E., & Giorgino, F. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110836 · Cited by 4
Metadata
- Authors
- Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S.
- Affiliations
- University of California San Diego (US)
- University of California, San Francisco (US)
- Endeavor Health (US)
- Mid America Diabetes Associates, Wichita, Kansas
- Health Management Resources, Carmel, Indiana
- Biostat International, Tampa, Florida
- Roche Diagnostics, Indianapolis, Indiana
- Corresponding author
- Parkin, Christopher G.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 262-267
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024331
- OpenAlex
- W2102487069
- Semantic Scholar
- 074343a0d8101d85936aedd3d5e7285d19afe6d6
- Cited by
- 429
- References
- 26
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 20 · 2021: 27 · 2020: 21 · 2019: 26 · 2018: 28 · 2017: 25 · 2016: 47 · 2015: 37 · 2014: 31 · 2013: 44 · 2012: 43
- FWCI
- 37.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, glycemic control, HbA1c, insulin-naive patients, glycemic variability, treatment intensification, general well-being, primary care
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Patient Education as Topic, Patient Participation, Primary Health Care, Prospective Studies, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.